Interview on the Impact of Trade Agreements, Pharma Influence on Access to Medicines in Developing Countries

An interview with Essential Action’s Sarah Rimmington on global access to medicines aired on WRVU 91.1 FM in Nashville Tennessee on January 7, 2008.

In the interview with Project Question’s Lonnie Atkinson, Sarah explains how international trade agreements governing patent rules and the brand-name pharmaceutical industry work to restrict the introduction of low-cost generic copies of life-saving drugs in the developing world. The widespread lack of generic versions of many life-saving treatments is a significant contributing factor to the limited access poor people in developing countries have to them.

You can listen to the entire interview here.